Finally, to clarify the clinical significance of serum IGF-1 and EGF concentrations in PD patients, larger clinical and preclinical studies are needed to further explore the potential mechanism underlying changes in serum IGF-1 and EGF levels in patients with PD. Here, IGF1 is linked to Parkinson disease.